Group 1 - The company, Gaolan Co., Ltd. (300499.SZ), announced an expected net profit attributable to shareholders of 23.5 million to 30.5 million yuan for 2025, a significant recovery from a loss of 50.32 million yuan in the same period last year [2] - The performance improvement is primarily driven by the favorable conditions in the power industry, which have led to an increase in the delivery volume of water-cooled products, as well as growth in revenue and gross margin from high-power power electronics thermal management products [2] - Additionally, the increase in investment income from the joint venture Dongguan Silicon Xiang has contributed to the overall performance improvement [2]

南财智讯1月27日电，中稀有色发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为 10000万元—13000万元，预计同比扭亏；预计2025年全年归属于上市公司股东的扣除非经常性损益的净 利润为13000万元—16000万元。本期业绩扭亏的主要原因：（一）2025年稀土市场行情整体呈上涨趋 势，公司紧跟市场行情积极把握机遇，通过强化市场研判、统筹企业管理、加强上下游营销业务协同， 并创新市场营销模式，推动稀土冶炼分离与永磁材料产销量实现增长，从而达成预期利润。第四季度因 中重稀土产品价格下降、推进改革出清以及确认参股企业投资减值等因素影响，公司第四季度业绩有所 下滑。（二）2025年公司持续聚焦主业发展，加大力度清理低效资产、退出亏损企业，不断优化资产结 构，从根本上减少亏损源。因上述改革出清等工作承担相关改革成本，影响了公司当期部分损益。 （三）公司参股企业大宝山公司保持稳产高产，因报告期内铜硫钙价格持续上涨，企业盈利增加，公司 按权益法核算的投资收益金额增加。 ...

何氏眼科公告，预计2025年度净利润为2400万元–3600万元，上年同期亏损2739.82万元。报告期内，公 司业绩实现扭亏为盈，得益于业务结构优化、成本费用有效控制及低效资产出清，公司盈利能力显著增 强。 ...

新京报贝壳财经讯1月26日，中国稀土（000831）发布业绩预告，预计2025年归母净利润为1.43亿元一 1.85亿元，同比扭亏为盈，上年同期亏损2.87亿元。公告显示，2025年上半年，稀土市场行情整体上 涨，公司调整营销策略、把握采销节奏，实现销售同比增长，有效提升经营创效水平。但下半年，受市 场环境、供需调节等因素影响，部分中重稀土产品价格下行，根据会计准则要求，第四季度计提存货跌 价准备金额环比增加，冲减了公司部分利润。 ...

智通财经APP讯，大连圣亚(600593.SH)发布公告，公司预计2025年年度实现归属于母公司所有者的净 利润2200万元到3300万元，与上年同期相比，将实现扭亏为盈。 ...

Core Viewpoint - Zhongyi Technology is expected to achieve a net profit attributable to shareholders of 60 million to 80 million yuan in 2025, indicating a turnaround from losses, with a significant increase in net profit excluding non-recurring gains and losses projected at 25 million to 35 million yuan, representing a year-on-year growth of 119.15% to 126.81% [1] Group 1: Financial Performance - The company anticipates a net profit of 60 million to 80 million yuan for the year 2025, marking a return to profitability [1] - The expected net profit excluding non-recurring items is projected to be between 25 million and 35 million yuan, reflecting a year-on-year increase of 119.15% to 126.81% [1] Group 2: Factors Influencing Performance - The improvement in performance is attributed to the recovery in industry conditions, leading to an increase in average processing fees for copper foil products [1] - The company has actively developed new customers and optimized its customer structure, resulting in steady growth in product sales [1] - Continuous optimization of product structure and an increase in the sales proportion of high value-added products have significantly enhanced the company's profitability [1] - The commitment to technological innovation and ongoing improvements in production processes have positively impacted net profit [1]

Core Viewpoint - ST Dehao is expected to turn a profit in 2025, with a projected net profit attributable to shareholders ranging from 22 million to 33 million RMB, despite a significant expected loss in net profit excluding non-recurring items, estimated between -14,200 million and -13,300 million RMB [1] Group 1: Revenue and Profit Forecast - The company anticipates a decline in revenue from its small home appliance export business, with a decrease of approximately 12% to 16% compared to the previous year [1] - The LED packaging business is expected to see a revenue decline of about 6% to 8% year-on-year, despite an increase in sales volume, due to reduced overseas backlight orders and intensified industry competition [1] - The impact of ongoing business operations on net profit attributable to shareholders is estimated to be between -6,800 million and -9,500 million RMB, reflecting a reduction in losses of approximately 6,200 million to 3,500 million RMB compared to the previous year, with a year-on-year loss reduction of about 27% to 47% [1] Group 2: Asset Management and Non-Recurring Items - Following the termination of the LED business, the company will continue to depreciate and prepare for asset impairment on unsold related assets, which is expected to negatively impact net profit attributable to shareholders by approximately -4,700 million to -6,500 million RMB [1] - The company estimates that non-recurring items will positively influence net profit by approximately 15,500 million to 17,500 million RMB, primarily from the disposal of idle assets in Dalian and the gradual settlement of historical debts leading to debt restructuring gains [1]

Core Viewpoint - Zhaojin Gold (SZ000506) reached its daily limit on January 26, 2026, with a price of 21.43 yuan, marking a 10.01% increase, and a total market capitalization of 19.909 billion yuan [1] Group 1: Company Performance - On January 26, 2026, Zhaojin Gold announced its 2025 annual report, indicating a turnaround with a net profit attributable to shareholders ranging from 122 million to 182 million yuan, highlighting improved operational performance [2] - The company's core asset, the Fiji Vatukoula Gold Mine, has been consistently producing high-quality gold and concentrates, contributing to the positive financial results [2] Group 2: Market Environment - Recent highs in gold futures have created a favorable market environment for gold companies, benefiting Zhaojin Gold as gold prices continue to rise [2] - The company has outlined resource planning for 2026, focusing on enhancing exploration efforts and cautiously evaluating external acquisition opportunities to strengthen resource security and market competitiveness [2] Group 3: Market Activity - On January 20, 2026, Zhaojin Gold was included in the "Dragon and Tiger List," with significant institutional and foreign capital buying, indicating strong market interest in the company [2] - The precious metals sector saw active performance from multiple stocks, contributing to a sector-wide momentum that positively impacted Zhaojin Gold [2] Group 4: Technical Analysis - Technical indicators such as K-line and MACD suggest potential further analysis; if the MACD forms a golden cross and the stock price breaks through key resistance levels, it may attract more technical investors, driving the stock price higher [2]

Core Viewpoint - MicroPort Medical (00853) expects to turn a profit in 2025, projecting a net profit of at least $20 million, driven by continuous revenue growth, particularly from overseas business, which has seen approximately 70% year-on-year growth [1] Financial Performance - The company anticipates a turnaround primarily due to sustained revenue growth, with overseas business contributing significantly [1] - Despite facing downward pressure on product prices from domestic industry policies, the company has improved its gross margin by 2-3 percentage points year-on-year through cost optimization measures [1] - Operating expenses have decreased by approximately 10-11% year-on-year during the reporting period [1] - The disposal of subsidiary companies has also contributed positively to MicroPort Medical's financial performance [1] Stock Market Reaction - Following the earnings announcement, MicroPort Medical's stock price opened high on January 23, reaching a peak increase of 12.84% before closing with a gain of less than 4% [3] - The trading volume on that day reached 77.07 million shares, setting a new record since October of the previous year, indicating significant investor activity [3] Historical Stock Performance - Since peaking at 16.28 HKD on October 8, the stock has experienced a two-month downtrend, with a maximum fluctuation of 39.80%, dropping to a low of 9.80 HKD [5] - The stock underwent a technical correction, moving from the upper to the lower Bollinger Band over a month, indicating a bearish market sentiment [5][6] Investor Sentiment and Trading Patterns - The stock's decline was characterized by low trading volumes, suggesting a lack of market support and internal disagreements among shareholders [5] - On November 24, the stock began a rebound after reaching a technical bottom, with subsequent trading showing a recovery trend [6][8] Institutional Investment Trends - Recent trading data indicates that Hong Kong Stock Connect funds have increased their holdings in MicroPort Medical, reversing previous trading strategies [9][11] - The average holding cost for these funds is 11.23 HKD, with an overall profit margin of 15.46% [9] Future Outlook - Analysts have raised profit forecasts for MicroPort Medical, reflecting improved operational efficiency and a focus on core business areas [12] - The company aims to achieve specific financial targets for 2025 and 2026, including a net profit of at least $45 million in the first half of 2026 [12]

一、本期业绩预计情况 1.业绩预告期间：2025年1月1日至2025年12月31日 2.业绩预告情况：√扭亏为盈 □同向上升 □同向下降 二、与会计师事务所沟通情况 公司就本期业绩预告与会计师事务所进行了预沟通，公司与会计师事务所在本期业绩预告方面不存在重 大分歧。因2025年度审计工作尚在进行中，具体数据以审计结果为准。 三、业绩变动原因说明 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000506 证券简称：招金黄金 公告编号：2026-002 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 四、 风险提示 本次预告的公司2025年度业绩仅为财务部门初步核算数据，具体财务数据以公司披露的2025年年度报告 为准。 《证券时报》《中国证券报》《证券日报》《上海证券报》和巨潮资讯网（www.cninfo.com.cn）为公 司指定的信息披露媒体，公司所有信息均以在上述媒体刊登的正式公告为准。 公司特别提醒广大投资者注意投资风险，理性决策，审慎投资。 特此公告。 招金国际黄金股份有限公司董事会 2026年1月26日 公司预计2025年度扭亏为盈， ...